NDC 58468-0050

XENPOZYME

Olipudase Alfa-rpcp

XENPOZYME is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Genzyme Corporation. The primary component is Olipudase Alfa.

Product ID58468-0050_090d024d-27b6-4b40-b628-a49d58ddfca4
NDC58468-0050
Product TypeHuman Prescription Drug
Proprietary NameXENPOZYME
Generic NameOlipudase Alfa-rpcp
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-08-31
Marketing CategoryBLA /
Application NumberBLA761261
Labeler NameGenzyme Corporation
Substance NameOLIPUDASE ALFA
Active Ingredient Strength20 mg/5.1mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 58468-0050-1

1 VIAL in 1 CARTON (58468-0050-1) > 5.1 mL in 1 VIAL
Marketing Start Date2022-08-31
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [XENPOZYME]

Mark Image

Registration | Serial
Company
Trademark
Application Date
XENPOZYME
XENPOZYME
90407808 not registered Live/Pending
Genzyme Corporation
2020-12-23
XENPOZYME
XENPOZYME
88330513 not registered Live/Pending
Genzyme Corporation
2019-03-07
XENPOZYME
XENPOZYME
86756168 not registered Dead/Abandoned
Genzyme Corporation
2015-09-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.